ArticleCPT: pharmacometrics & systems pharmacology2026
Tackling High Dimensionality in QSP: Guiding Model Order Reduction With Index Analysis.
Article in CPT: pharmacometrics & systems pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tackling High Dimensionality in QSP: Guiding Model Order Reduction With Index Analysis.CPT: pharmacometrics & systems pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Quantitative systems pharmacology (QSP) models offer a useful platform to integrate drug pharmacology with knowledge about biological mechanisms across multiple scales and data sources into a unified quantitative framework. This makes them invaluable to address many relevant questions in drug research and development. Despite their potential, however, QSP models are seldom employed in the population analysis context due to their complexity and dimensionality. Model order reduction (MOR) techniques can be used to tackle this challenge. However, a single MOR technique might not be sufficient to achieve an applicable reduced model. Furthermore, to date there is no tool to judge whether the reduced model retains important mechanistic features of the original model. In this tutorial, we present a workflow employing index analysis that guides the selection and combination of MOR techniques and includes a check of the preservation of important mechanistic features by the reduced model. To demonstrate the value of the proposed approach, we first explain the concepts in the context of a small-scale example model and then expand to a well-known large-scale QSP model-the blood coagulation model.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.